Recombinant Human Alpha-synuclein protein aggregate (Active)
Be the first to review this product! Submit a review
|
(14 Publications)
Recombinant Human Alpha-synuclein protein aggregate (Active) is a Human Full Length SNCA protein, in the 1 to 140 aa range with >95% purity, <= 20 EU/mL endotoxin level and suitable for western blot, Functional studies and SDS-PAGE. The predicted molecular weight of ab218819 recombinant protein is 14.5 kDa.
- Suitable for Thioflavin T Fluorescence assay
- Save time and ensure accurate results - use recombinant Alpha-synuclein (SNCA) protein
- Optimal protein bioactivity, stability and reproducibility
View Alternative Names
NACP, PARK1, SNCA, Alpha-synuclein, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Recombinant Human Alpha-synuclein protein aggregate (Active) (AB218819)
Immunohistochemical analysis of primary rat hippocampal neurons showing lewy body inclusion formation when treated with active Alpha Synuclein Protein Aggregate (ab218819) at 4 μg/ml (D-F), but not when treated with control Alpha Synuclein Protein Aggregate (ab218817) at 4 μg/ml (A-C). Tissue : Primary hippocampal neurons. Species : Sprague-Dawley rat. Fixation : 4% formaldehyde from PFA. Primary antibody : Mouse anti-pSer129 Antibody at 1/1000 24 hours at 4°C. Secondary antibody : FITC Goat Anti-Mouse (green) at 1/700 for 1 hour at RT. Counterstain : Hoechst (blue) nuclear stain at 1/4000 for 1 hour at RT. Localization : Lewy body incluscions. Magnification : 20x.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Recombinant Human Alpha-synuclein protein aggregate (Active) (AB218819)
ab218819 was shown to be taken up by SH-SY5Y cells and transmitted to neuronal iPSCs within 14 days. Blue : Hoechst/DNA; Green : SHSY5Y-GFP; Red : Alpha-synuclein protein aggregate (ab218819); Purple : Tubulin.
- EM
Supplier Data
Electron Microscopy - Recombinant Human Alpha-synuclein protein aggregate (Active) (AB218819)
TEM of active human alpha synuclein preformed fibrils (ab218819) (top) and control (inactive) human alpha synuclein preformed fibrils (ab218817) (bottom). Fibrils were sonicated and treated with uranyl acetate. The active fibrils are shorter than the inactive fibrils.
- FuncS
Supplier Data
Functional Studies - Recombinant Human Alpha-synuclein protein aggregate (Active) (AB218819)
ab218819 seeds the formation of new alpha synuclein fibrils from the pool of alpha synuclein monomers.
Thioflavin T is a fluorescent dye that binds to beta sheet-rich structures, such as those in alpha synuclein fibrils. Upon binding, the emission spectrum of the dye experiences a red-shift, and increased fluorescence intensity.
Thioflavin T emission curves show increased fluorescence (correlated to alpha synuclein protein aggregation) over time when 10 μM of ab218819 is combined with 100 μM of alpha synuclein monomer, as compared to ab218819 alone and alpha synuclein monomer alone.
Thioflavin T ex = 450 nm, em = 485 nm.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Recombinant Human Alpha-synuclein protein aggregate (Active) (AB218819)
Immunohistochemistry analysis of rat brain injected with active human alpha synuclein PFFs (ab218819). Species : Female Sprague-Dawley Rat. Rat was injected with 2μL active human alpha synuclein PFFs (ab218819) in each of 2 injection sites : AP+1.6, ML+2.4, DV-4.2 from skull; and AP-1.4, ML+0.2, DV-2.8 from skull. 30-days post-injection. Fixation : Saline perfusion followed by 4% PFA fixation for 48 hrs. Secondary Antibody : Biotin-SP Donkey Anti-Rabbit IgG (H+L) at 1 : 500 for 2 hours in cold room with shaking. ABC signal amplification, DAB staining. Alpha synuclein pathology is seen in the striatum close to an injection site.
- EM
Supplier Data
Electron Microscopy - Recombinant Human Alpha-synuclein protein aggregate (Active) (AB218819)
TEM of Type 1 Alpha Synuclein Pre-formed Fibrils (PFFs) (ab218819)
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Recombinant Human Alpha-synuclein protein aggregate (Active) (AB218819)
Immunocytochemistry/Immunofluorescence analysis of human iPSC-derived neurons treated with alpha synuclein pre-formed fibrils (ab218819). Primary Antibody : Mouse Anti-Alpha Synuclein (pSer129) Monoclonal Antibody at 1 : 1000 for O/N at 4°C. Secondary Antibody : Anti-Rabbit : A488 at 1 : 1000 for 1 hour at RT. Magnification : 40X. Nuclear stain : Hoechst- 20 min, RT (blue). Actin stain : Phalloidin-647- 20 min, RT (magenta). 4K cells per well. Negative control; no fibrils added to well. B) 7 days after addition of active recombinant human pre-formed fibrils (Type 1). Fibrils were sonicated before use and applied 2.5 ug per well
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human Alpha-synuclein protein aggregate (Active) (AB218819)
SDS-PAGE analysis of ab218819.
Reactivity data
Product details
ab218819 can be used as a positive control in SDS-PAGE and western blot assays.
Check out our Thioflavin T assay protocol here.
For best results, sonicate ab218819 immediately prior to use. Sonication of PFFs is required in order to obtain fibrils with an average length of ~50nm, the optimal size for pathology.
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The alpha-synuclein protein plays critical roles in neuronal activity. It contributes to neurotransmitter release regulation by acting in the formation and plasticity of the presynaptic neuronal network. Alpha-synuclein doesn't usually form parts of large protein complexes but it may associate transiently with membranes and vesicular structures. The protein's monomer form has also been observed in alpha lines and related neuronal processes operating alongside various cellular functions.
Pathways
Synaptic vesicle trafficking and dopamine neurotransmitter release are significant areas involving the alpha-synuclein protein. In these pathways alpha-synuclein interacts with other proteins like synaptophysin and protein monomer monomerizations are intrinsic to these processes. Altered function or aggregation of alpha-synuclein disrupts these pathways influencing broader neurological functions.
Specifications
Form
Liquid
Additional notes
ab218819 was purified by ion-exchange.
General info
Function
Neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release (PubMed : 20798282, PubMed : 26442590, PubMed : 28288128, PubMed : 30404828). Participates as a monomer in synaptic vesicle exocytosis by enhancing vesicle priming, fusion and dilation of exocytotic fusion pores (PubMed : 28288128, PubMed : 30404828). Mechanistically, acts by increasing local Ca(2+) release from microdomains which is essential for the enhancement of ATP-induced exocytosis (PubMed : 30404828). Also acts as a molecular chaperone in its multimeric membrane-bound state, assisting in the folding of synaptic fusion components called SNAREs (Soluble NSF Attachment Protein REceptors) at presynaptic plasma membrane in conjunction with cysteine string protein-alpha/DNAJC5 (PubMed : 20798282). This chaperone activity is important to sustain normal SNARE-complex assembly during aging (PubMed : 20798282). Also plays a role in the regulation of the dopamine neurotransmission by associating with the dopamine transporter (DAT1) and thereby modulating its activity (PubMed : 26442590).
Sequence similarities
Belongs to the synuclein family.
Post-translational modifications
Phosphorylated, predominantly on serine residues. Phosphorylation by CK1 appears to occur on residues distinct from the residue phosphorylated by other kinases. Phosphorylation of Ser-129 is selective and extensive in synucleinopathy lesions. In vitro, phosphorylation at Ser-129 promoted insoluble fibril formation. Phosphorylated on Tyr-125 by a PTK2B-dependent pathway upon osmotic stress.. Hallmark lesions of neurodegenerative synucleinopathies contain alpha-synuclein that is modified by nitration of tyrosine residues and possibly by dityrosine cross-linking to generated stable oligomers.. Ubiquitinated. The predominant conjugate is the diubiquitinated form.. Acetylation at Met-1 seems to be important for proper folding and native oligomeric structure.
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 22:e00538 PubMed39904669
2025
Applications
Unspecified application
Species
Unspecified reactive species
Military Medical Research 11:48 PubMed39034405
2024
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 7: PubMed38609183
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 21:81 PubMed38566081
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced materials (Deerfield Beach, Fla.) 35:e2304654 PubMed37753928
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 30:2280-2292 PubMed37633968
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed37174736
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 11: PubMed36497031
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 13:833515 PubMed35309340
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 12: PubMed35204664
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com